Akèy › Kolestewòl › North Carolina
Etid klinik pou Kolestewòl nan North Carolina
7 etid pou Kolestewòl ap chèche patisipan nan sit nan North Carolina.
Vil nan North Carolina
Tèks ofisyèl etid la (Anglè)
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Asheville Cardiology Associates Research Department, Asheville
- Novant Health Clinical Research/Heart & Vascular Institute, Charlotte
- Mecklenburg Heart Specialists, Charlotte
- ak 6 plis
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06909565A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
- Duke Early Phase Clinical Research, Durham
- Peters Medical Research, High Point
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Sep 18, 2026 · NCT07491172A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
- Research Site, Durham
- Research Site, Morehead City
- Research Site, Statesville
- ak 2 plis
Ap rekriteFaz 3
Laj 18 a 130 · Tout sèks · Mizajou Sep 10, 2026 · NCT07619131A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Monroe Biomedical Research, Monroe
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Jul 30, 2026 · NCT07610278A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Velocity Clinical Research - Durham, Durham
- Accellacare of Wilmington, Wilmington
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Jul 22, 2026 · NCT07477704Pharmacogenomic Informed Statin Prescribing
- Durham VA Medical Center, Durham, NC, Durham
Ap rekrite
Laj 40 a 75 · Tout sèks · Mizajou Apr 13, 2026 · NCT06568601Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
- Wake Forest University Health Sciences, Winston-Salem
Ap rekriteFaz 2
Laj 40 a 75 · Tout sèks · Mizajou Feb 27, 2026 · NCT06488105Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.